Recherche
S'identifier
mercredi 13 septembre 2017
Tous les titres

 

Fax du mercredi 13 septembre 2017 - Tous les titres

go back Retour << Article précédent     Article suivant >>

 

Selectra J. Lamarck Biotech Sub-Fund Earns 5-Star Morninstar Rating

SELECTRA is pleased to announce that the J. Lamarck Biotech Sub-Fund (the “Fund”) received a ***** (5-star) Morningstar RatingTM for its institutional “C” fund class.   The USD denominated class of the J. Lamarck sub-fund received an Overall five-star Morningstar Rating™ as of August 31, 2017 based on risk-adjusted returns for the 3-year period. The Morningstar Rating™, commonly known as the star rating, rates mutual funds from one to five stars, with the best performers receiving five stars.   The rating is an assessment of a fund’s past performance – based on both return and risk – which shows how similar investments compare with their competitors. The J. Lamarck Biotech Sub-Fund is rated within the top 10% of the Sector Equity Biotechnology category,...
Cette page n'est accessible qu'aux abonnés payants.
Veuillez vous identifier si vous êtes abonnés à la consultation de nos archives.
Nous vous invitons à souscrire un abonnement, ou à prendre contact avec nous.

This page is only accessible to paying subscribers.
Please identify yourself if you have subscribed to the consultation of our archives.
We invite you to take out a subscription, or to contact us.
Ces entreprises nous font bénéficier de  leur expertise en collaborant avec Agefi Luxembourg.

These companies give us the benefit of their expertise by collaborating with Agefi Luxembourg.
Mazars.lu
VP Bank
Bearingpoint
Linklaters
Lpea.lu
Pictet Asset Management
Lamboley Executive Search
Square management
Generali Investements LU
DLA PIPER
MIMCO Capital
Fi&FO
Allen & Overy
J. P. Morgan
SOCIETE GENERALE Securities Services
Castegnaro
Stibbe
Zeb Consulting
Loyens & Loeff
NautaDutilh
AXA IM Luxembourg
Comarch
Paragon
Sia Partners
Ernst&Young